-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MO8LSp4KT9BlSpLOsvWioPqi9kULijYjf85Ltxp0p9H0GTn3MNoh/K7cnLLbthLH Lvvfmpr6JIUmA09EERmvBA== 0001181431-07-077445.txt : 20071226 0001181431-07-077445.hdr.sgml : 20071225 20071226111945 ACCESSION NUMBER: 0001181431-07-077445 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071226 FILED AS OF DATE: 20071226 DATE AS OF CHANGE: 20071226 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SHARPS COMPLIANCE CORP CENTRAL INDEX KEY: 0000898770 STANDARD INDUSTRIAL CLASSIFICATION: HAZARDOUS WASTE MANAGEMENT [4955] IRS NUMBER: 742657168 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 9350 KIRBY DRIVE STREET 2: STE 300 CITY: HOUSTON STATE: TX ZIP: 77054 BUSINESS PHONE: 713-432-0300 MAIL ADDRESS: STREET 1: 9350 KIRBY DRIVE STREET 2: STE 300 CITY: HOUSTON STATE: TX ZIP: 77054 FORMER COMPANY: FORMER CONFORMED NAME: US MEDICAL SYSTEMS INC DATE OF NAME CHANGE: 19970128 FORMER COMPANY: FORMER CONFORMED NAME: MEDICAL POLYMERS TECHNOLOGIES INC DATE OF NAME CHANGE: 19930916 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mayfield David C CENTRAL INDEX KEY: 0001394488 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22390 FILM NUMBER: 071325466 BUSINESS ADDRESS: BUSINESS PHONE: 713 432 0300 MAIL ADDRESS: STREET 1: 9220 KIRBY DRIVE STREET 2: SUITE 500 CITY: HOUSTON STATE: TX ZIP: 77054 4 1 rrd184529.xml MAYFIELD CHANGE IN POSITION X0202 4 2007-12-26 1 0000898770 SHARPS COMPLIANCE CORP SCOM 0001394488 Mayfield David C 9220 KIRBY DRIVE SUITE 500 HOUSTON TX 77054 0 0 0 1 Former Officer Sharps Compliance Corp. Common Stock 3.28 2007-12-26 2007-12-26 4 J 0 75000 3.28 D 2008-04-09 2014-04-09 Common Stock 75000 25000 D Represents the forfeiture of 75,000 stock options previously granted on April 9, 2007. Vesting 33.3% on each April 9, 2008, 2009 and 2010. Mr. Mayfield, the Company's prior Sr. V P of Sales & Marketing, accepted the non-officer position of V P of Pharmaceutical Sales and Reimbursement effective December 26, 2007. Lynn Carnes 2007-12-26 -----END PRIVACY-ENHANCED MESSAGE-----